Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase

. 2012 Sep ; 92 (5) : 434-9. [epub] 20120704

Jazyk angličtina Země Scotland Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid22765970
Odkazy

PubMed 22765970
DOI 10.1016/j.tube.2012.06.001
PII: S1472-9792(12)00132-1
Knihovny.cz E-zdroje

The global burden of tuberculosis, its health and socio-economic impacts, the presence of drug-resistant forms and a potential threat of latent tuberculosis should serve as a strong impetus for the development of novel antituberculosis agents. We reported the in vitro activity of salicylanilide benzoates and pyrazine-2-carboxylates against Mycobacterium tuberculosis (minimum inhibitory concentrations as low as 0.5 μmol/L). Nineteen salicylanilide derivatives with mostly good antimycobacterial activity were evaluated for the inhibition of two essential mycobacterial enzymes, methionine aminopeptidase and isocitrate lyase, which are necessary for the maintenance of the latent tuberculosis infection. Salicylanilide derivatives act as moderate inhibitors of both mycobacterial and human methionine aminopeptidase and they also affect the function of mycobacterial isocitrate lyase. 4-Bromo-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl pyrazine-2-carboxylate was the most potent inhibitor of mycobacterial methionine aminopeptidase (41% inhibition at 10 μmol/L) and exhibited the highest selectivity. 5-Chloro-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide and 4-chloro-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl pyrazine-2-carboxylate caused 59% inhibition of isocitrate lyase at 100 μmol/L concentration and (S)-4-bromo-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl 2-acetamido-3-phenylpropanoate produced 22% inhibition at 10 μmol/L; this rate is approximately comparable to 3-nitropropionic acid. Inhibition of those enzymes contributes at least in part to the antimicrobial activity of the compounds.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Salicylanilides and Their Anticancer Properties

. 2023 Jan 15 ; 24 (2) : . [epub] 20230115

Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity

. 2017 Sep 19 ; 22 (9) : . [epub] 20170919

Antiproliferative and Pro-Apoptotic Effect of Novel Nitro-Substituted Hydroxynaphthanilides on Human Cancer Cell Lines

. 2016 Jul 28 ; 17 (8) : . [epub] 20160728

Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates

. 2016 Feb 11 ; 21 (2) : . [epub] 20160211

In vitro bactericidal activity of 4- and 5-chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA

. 2015 ; 2015 () : 349534. [epub] 20150115

Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes

. 2014 ; 2014 () : 703053. [epub] 20141104

Antibacterial and herbicidal activity of ring-substituted 2-hydroxynaphthalene-1-carboxanilides

. 2013 Aug 06 ; 18 (8) : 9397-419. [epub] 20130806

Antibacterial and herbicidal activity of ring-substituted 3-hydroxynaphthalene-2-carboxanilides

. 2013 Jul 08 ; 18 (7) : 7977-97. [epub] 20130708

Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates

. 2013 Mar 25 ; 18 (4) : 3674-88. [epub] 20130325

Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains

. 2012 Oct 31 ; 17 (11) : 12812-20. [epub] 20121031

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...